Nintx at the 2025 Ganepão Congress

The company presented its innovative technologies, pipeline, and vision for the future of therapies based on the human gut microbiome to physicians and nutritionists from Brazil

The symposium, "New Generation of Gut Microbiome-Centered Therapies," was moderated by Stephani Saverio (CEO) and featured presentations by Dr. Cristiano R. W. Guimaraes (CSO), Dr. Miller Freitas (CDO), and Dr. Katia Sivieri, Head of Nintx's microbiome laboratory. For Nintx, understanding and mastering the science of the human microbiome is essential to creating increasingly personalized therapies − and this will be crucial for the future of healthcare.

To have access to the full content, check us out on LinkedIn.

https://www.linkedin.com/posts/nintx_a-nintx-marcou-presen%C3%A7a-no-congresso-ganep%C3%A3o-activity-7339374789855215616--6xb?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAAUL6oB6dOVqNQ7Ria1q2TMTlnb4Jf7Jwk